Article
Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning.
BMC research notes - 27 Jan 2018
Olesen Anne Estrup, Grønlund Debbie, Gram Mikkel, Skorpen Frank, Drewes Asbjørn Mohr, Klepstad Pål
Abstract excerpt
OBJECTIVE: Use of opioids for pain management has increased over the past decade; however, inadequate analgesic response is common. Genetic variability may be related to opioid efficacy, but due to the many possible combinations and variables, statistical computations may be difficult. This study investigated whether data processing with support vector machine learning could predict required opioid dose in cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.